APA (7th ed.) Citation

Dbaibo, G. S., Balik, I., Akdemir, İ., Buzgan, T., Guner, R., Boutros, C. F., . . . Ceyhan, M. (2026). Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study. Infectious Diseases & Therapy, 15(3), 769. https://doi.org/10.1007/s40121-025-01298-w

Chicago Style (17th ed.) Citation

Dbaibo, Ghassan S., et al. "Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study." Infectious Diseases & Therapy 15, no. 3 (2026): 769. https://doi.org/10.1007/s40121-025-01298-w.

MLA (9th ed.) Citation

Dbaibo, Ghassan S., et al. "Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study." Infectious Diseases & Therapy, vol. 15, no. 3, 2026, p. 769, https://doi.org/10.1007/s40121-025-01298-w.